Authors: CAGNONI PJ JONES RB BEARMAN SI ROSS M HAMI L FRANKLIN WA CAPIZZI R SCHEIN PS SHPALL EJ

Citation: Pj. Cagnoni et al., USE OF AMIFOSTINE IN BONE-MARROW PURGING, Seminars in oncology, 23(4), 1996, pp. 44-48

Authors: FACCHINI T BELPOMME D KEMP G ROSE P ROULLET B PHILLIPS P SCHEFFLER BJ OSTER W CAPIZZI RL SCHEIN PS

Citation: T. Facchini et al., AMIFOSTINE (AMI) SELECTIVELY PROTECTS AGAINST CUMULATIVE TOXICITIES OF CYCLOPHOSPHAMIDE (C) AND CISPLATIN (P), European journal of cancer, 31A, 1995, pp. 500-500

Authors: CAPIZZI RL SCHEFFLER BS OSTER W HABBOUBI N SCHEIN PS

Citation: Rl. Capizzi et al., AMIFOSTINE REDUCES CUMULATIVE CISPLATIN NEPHROTOXICITY, European journal of cancer, 31A, 1995, pp. 577-577

Authors: KALEBIC T SCHEIN PS

Citation: T. Kalebic et Ps. Schein, ORGANIC THIOPHOSPHATE WR-151327 SUPPRESSES EXPRESSION OF HIV IN CHRONICALLY INFECTED-CELLS, AIDS research and human retroviruses, 10(6), 1994, pp. 727-733

Authors: SHPALL EJ STEMMER SM HAMI L FRANKLIN WA SHAW L BONNER HS BEARMAN SI PETERS WP BAST RC MCCULLOCH W CAPIZZI R MITCHELL E SCHEIN PS JONES RB

Citation: Ej. Shpall et al., AMIFOSTINE (WR-2721) SHORTENS THE ENGRAFTMENT PERIOD OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE-PURGED BONE-MARROW IN BREAST-CANCER PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT, Blood, 83(11), 1994, pp. 3132-3137

Authors: CAPIZZI RL SCHEFFLER BJ SCHEIN PS

Citation: Rl. Capizzi et al., AMIFOSTINE-MEDIATED PROTECTION OF NORMAL BONE-MARROW FROM CYTOTOXIC CHEMOTHERAPY, Cancer, 72(11), 1993, pp. 3495-3501